Imaging modalities like OCT, and AO-SLO have transformed our ability to stage and diagnose retinal disease. But in many respects it’s only showing you the pathologic structural changes that occur after the damage has been done. Take the example of diabetic retinopathy. By the time a patient begins to notice problems with their vision, they’ve lost a significant portion of it – and a hefty number of cells in the retina too. Much like age-related macular degeneration (AMD) and glaucoma, interventions at this point are almost palliative: current therapies try to slow the diseases progression, but they can’t replace what’s lost.
But what if you could detect disease processes before permanent damage has happened? At a point where early, disease-altering interventions – some as simple as lifestyle changes – could be made? Sound unrealistic? Apparently not. It seems there is a way - by using mitochondrial function as a marker of retinal health.
Enjoy our FREE content!
Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE and always will be!
If you don’t have an account you can:
REGISTER NOW – it’s FREE and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Ophthalmologist magazine
Or Login as a Guest or via Social Media
This will allow you to read this article but you will only have limited access to The Ophthalmologist.Login as Guest Twitter LinkedIn Google+ Facebook